Academic Title:
Professor
Primary Appointment:
Orthopaedics
Email:
Phone (Primary):
For an appointment call 410-448-6400
Education and Training
- Stanford University, B.A.S., 1992
- Vanderbilt University, MD, 1996
- Duke University, Residency in Orthopaedic Surgery, 2002
- University of Toronto, Fellowship in Orthopaedic Oncology, 2004
Biosketch
Michelle Ghert, MD, FRCSC, is an orthopaedic surgeon specializing in musculoskeletal oncology. She has extensive experience in the diagnosis and surgical management of benign and malignant tumors of the musculoskeletal system and in complex limb reconstruction. Dr. Ghert is also a national and international leader in sarcoma care and multidisciplinary management. Dr. Ghert leads international randomized controlled trials in orthopaedic oncology, including the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) trial (NCT01479283) and the Surveillance after Extremity Tumor Surgery (SAFETY) randomized controlled trial (safetyrct.com, NCT03944798).
Dr. Ghert completed her pre-medical studies at Stanford University in California and received her medical degree from Vanderbilt University in Tennessee. She completed her residency in orthopaedic surgery at Duke University in North Carolina, and her musculoskeletal oncology fellowship at the University of Toronto in Ontario, Canada. She began her independent clinical and academic career as Assistant Professor at McMaster University in Hamilton, Ontario, Canada in 2005, and was promoted to Professor in 2017. Dr. Ghert was recruited to the University of Maryland where she opened her clinical practice in 2024.
Research/Clinical Keywords
randomized controlled trials,orthopaedic oncology, musculoskeletal tumors, surgery, sarcoma, skeletal metastases
Highlighted Publications
Most Highly Cited Publications
Ghert, Michelle, et al. "Comparison of prophylactic intravenous antibiotic regimens after endoprosthetic reconstruction for lower extremity bone tumors: a randomized clinical trial." JAMA oncology 8.3 (2022): 345-353.
Mak, Isabella WY, Nathan Evaniew, and Michelle Ghert. "Lost in translation: animal models and clinical trials in cancer treatment." American journal of translational research 6.2 (2014): 114.
Pervaiz, N., Colterjohn, N., Farrokhyar, F., Tozer, R., Figueredo, A., & Ghert, M. (2008). A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma. Cancer: Interdisciplinary International Journal of the American Cancer Society, 113(3), 573-581.
Additional Publication Citations
Awards and Affiliations
2023 Ann Doner Vaughan Kappa Delta Award
Ghert receives Kappa Delta Ann Doner Vaughn Award at AAOS Annual Meeting (healio.com)
2019 J. Édouard Samson Award:
Dr. Michelle Ghert for her research proposal entitled: “The Prophylactic Antibiotic Regimens in Tumour Surgery (PARITY) Trial: Unprecedented international collaboration in orthopaedic oncology” Journal of the American Medical Association Oncology: Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors A Randomized Clinical Trial
Other Affiliations
Professor, Part-Time, McMaster University
Grants and Contracts
Active Grants
NIH/NIAMS R34AR084146-01:
A Planning Grant for a Multi-Center Randomized Controlled Trial Comparing Resection and Endoprosthetic Reconstruction vs. Internal Fixation for Metastatic Bone Disease of the Proximal Femur
DOD CA230126:
Deficits in Cellular Redox Balance in Survivors of Lower-Extremity Sarcoma: A Potential Target for Improving Recovery Time, Function, and Quality of Life
Canadian Cancer Society Grant 70812:
The Proximal Femur Resection or Internal Fixation for Metastases (PERFORM) Pilot Randomized Controlled Trial